Loss of Bcl-2 in invasive breast cancer is associated with high rates of cell death, but also with increased proliferative activity

British Journal of Cancer

Volumn 77, Issue 5, 1998, Pages 789-796

  Van Slooten, H J ^a   Van De Vijver, M J ^a   Van De Velde, C J H ^a   Van Dierendonck, J H ^a   Duval, C ^b   Pallud, C ^c   Mandard, A M ^d   Delobelle Deroide, A ^e  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CENTRE HENRI BECQUEREL   (France)

^c CENTRE RENÉ HUGUENIN   (France)

^d Centre Franç Baclesse   (France)

^e CENTRE OSCAR LAMBRET   (France)

Author keywords

Apoptosis; Bcl 2; Breast cancer; Ki 67; p53; Proliferation

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; ARTICLE; BREAST CANCER; CELL DEATH; CELL DIVISION; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PREMENOPAUSE; PRIORITY JOURNAL;

EID: 0031933946     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.128     Document Type: Article

References (58)

1. Aihara M, Scardino PT, Truong LD, Wheeler TM, Goad JR, Yang G and Thompson TC (1995) The frequency of apoptosis correlates with the prognosis of Gleason Grade 3 adenocarcinoma of the prostate. Cancer 75: 522-529
2. Bhargava V, Kell DL, van de Rijn M and Warnke RA (1994) Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor Positivity. Am J Pathol 145: 535-539
3. Blagosklonny MV, Schulte T, Nguyen P, Trepel J and Neckers LM (1996) Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. Cancer Res 56: 1851-1854
4. Bodis S, Siziopikou KP, Schnitt SJ, Harris JR and Fisher DE (1996) Extensive apoptosis in ductal carcinoma in situ of the breast. Cancer 77: 1831-1835
5. Borner C (1996) Diminished cell proliferation associated with the death-protective activity of Bcl-2. J Biol Chem 271: 12695-12698
6. Brady HJM, Gil-Gomez G, Kirberg J and Berns AJM (1996) Bax-α perturbs T cell development and affects cell cycle entry of T cells. EMBO J 15: 6991-7001
7. Campos L, Rouault JP, Sabido O, Oriol P, Roubi N, Vasselon C, Archimbaud E, Magaud JP and Guyotat D (1993) High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood 81: 3091-3096
8. Chresta CM, Masters JRW and Hickman JA (1996) Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax:Bcl-2 ratio. Cancer Res 56: 1834-1841
9. Clahsen PC, Van de Velde CJH, Duval C, Pallud C, Mandard A, Delobelle-Deroide A, van den Broek L, Sahmoud TM and van de Vijver MJ (1997) P53 expression and response to chemotherapy in premenopausal node-negative women with early breast cancer. J Clin Oncol (in press)
10. Donaldson KL, Goolsby GL, Kiener PA and Wahl AF (1994) Activation of p34cdc2 coincident with taxol-induced apoptosis. Cell Growth Different 5: 1041-1050
11. Du M, Singh N, Husseuin A, Isaacson PG and Pan L (1996) Positive correlation between apoptotic and proliferative indices in gastrointestinal lymphomas of mucosa-associated lymphoid tissue (MALT). J Pathol 178: 379-384
12. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ and Hancock DC (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119-128
13. Field SJ, Tsai FY, Kuo F, Zubiaga AM, Kaelin WG, Jr., Livingston DM, Orkin SH and Greenberg ME (1996) E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85: 549-561
14. Gavrieli Y, Sherman Y and Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501
15. Graeber TG, Osmanian C, Jacks T, Houseman DE, Koch CJ, Lowe SW and Giaccia AJ (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours (see comments). Nature 379: 88-91
16. Guan RJ, Moss SF, Arber M, Krajewski S, Reed JC and Holt PR (1996) 30 kDa phosphorylated form of Bcl-2 protein in human colon. Oncogene 12: 2605-2609
17. Huang Y, Ray S, Reed JC, Ibrado AM, Tang C, Nawabi A and Bhalla K (1997) Estrogen increases intracellular p26bcl 2 to p21bax ratios and inhibits taxol induced apoptosis of human breast cancer MCF-7 cells. Breast Cancer Res Treat 42: 73-81
18. Isacson C, Kessis TD, Hedrick L and Cho KR (1996) Both cell proliferation and apoptosis increase with lesion grade in cervical neoplasia but do not correlate with human papillomavirus type. Cancer Res 56: 669-674
19. Joensuu H, Pylkkanen L and Toikkanen S (1994) Bcl-2 protein expression and long-term survival in breast cancer. Am J Pathol 145: 1191-1198
20. Kerr JFR, Winterford CM and Harmon BV (1994) Apoptosis: Its significance in cancer and cancer therapy. Cancer 73: 2013-2026
21. Ko LJ and Prives C (1996) p53: puzzle and paradigm. Genes Dev 10: 1054-1072
22. Korsmeyer SJ (1995) Regulators of cell death. (Review). Trends Genet 11: 101-105
23. Koshida Y, Saegusa M and Okayasu I (1996) Apoptosis, cell proliferation and expression of Bcl-2 and Bax in gastric carcinomas: immunohistochemical and clinocopathological study. Br J Cancer 75: 367-373
24. Krajewski S, Blomqvist C, Franssila K, Krajewska M, Wasenius VM, Niskanen E, Nordling S and Reed JC (1995) Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res 55: 4471-4478
25. Kranenburg O, van der Eb AJ and Zantema A (1996) Cyclin D1 is an essential mediator of apoptotic neuronal cell death. EMBO J 15: 46-54
26. Leek RD, Kaklamanis L, Pezzella F, Gatter KC and Harris AL (1994) Bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer. Br J Cancer 69: 135-139
27. Lipponen PK and Aaltomaa S (1994) Apoptosis in bladder cancer as related to standard prognostic factors and prognosis. J Pathol 173: 333-339
28. Lipponen P, Pietilainen T, Kosma VM, Aaltomaa S, Eskelinen M and Syrjanen K (1995) Apoptosis suppressing protein bcl-2 is expressed in well-differentiated breast carcinomas with favourable prognosis. J Pathol 177: 49-55
29. Lu PJ, Lu QL, Rughetti A and Taylor-Papadimitriou J (1995) bcl-2 overexpression inhibits cell death and promotes the morphogenesis, but not tumorigenesis of human mammary epithelial cells. J Cell Biol 129: 1363-1378
30. Morgenbesser SD, Williams BO, Jacks T and DePinho RA (1994) p53-dependent apoptosis produced by Rb-deficicncy in the developing mouse lens (see comments). Nature 371: 72-74
31. Naik P, Karrim J and Hanahan D (1996) The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors. Genes Dev 10: 2105-2116
32. O'Reilly LA, Huang DCS and Strasser A (1996) The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. EMBO J 15: 6979-6990
33. Pandey S and Wang E (1995) Cells en route to apoptosis are characterized by the upregulation of c-fos, c-myc, c-jun, cdc2, and RB phosphorylation, resembling events of early cell-cycle traverse. J Cell Biochem 58: 135-150
34. Pietenpol JA, Papadopoulos N, Markowitz S, Wilson JKV, Kinzler KW and Vogelstein B (1994) Paradoxical inhibition of solid tumor cell growth by bcl-2. Cancer Res 3714-3717
35. Reed J (1994) Mini-review: cellular mechanisms of disease series. Bcl-2 and the regulation of programmed cell death. J Cell Biol 124: 1-6
36. Sabourin JC, Martin A, Baruch J, Truc JB, Gompel A and Poitout P (1994) Bcl-2 expression in normal breast tissue during the menstrual cycle. Int J Cancer 59: 1-6
37. Schneider HJ, Sampson SA, Cunningham D, Norman AR, Andreyev HJN, Tilsed JVT and Clarke PA (1997) Bcl-2 expression and response to chemotherapy in colorectal adenocarcinomas. Br J Cancer 75: 427-131
38. Shi L, Nishioka WK, Th'ng J, Bradbury EM, Litchfield DW and Greenbeng AH (1994) Premature p34cdc2 activation required for apoptosis (see comments). Science 263: 1143-1145
39. 1. Nature 374: 811-813
40. Shimizu T, O'Connor PM, Kohn KW and Pommier Y (1995b) Unscheduled activation of cyclin B1/Cdc2 kinase in human promyelocytic leukemia cell line HL60 cells undergoing apoptosis induced by DNA damage. Cancer Res 55: 228-231
41. Shimizu S, Eguchi Y, Kamiike W, Waguri S, Uchiyama Y, Matsuda H and Tsujimoto Y (1996) Retardation of chemical hypoxia-induced necrotic cell death by Bcl-2 and ICE inhibitors: possible involvement of common mediators in apoptotic and necrotic signal transductions. Oncogene 12: 2045-2050
42. Shoji Y, Saegusa M, Takano Y, Ohbu M and Okayasu I (1996) Correlation of apoptosis with tumour cell differentiation, progression, and HPV injection in cervical carcinoma. J Clin Pathol 49: 134-138
43. Silvestrini R, Veneroni S, Daidone MG, Benini H, Boracchi P, Mezzetti M, Di Fronzo G, Rilke F and Veronesi U (1994) The bcl-2 protein: A prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients. J Natl Cancer Inst 86: 499-504
44. Silvestrini R, Benini H, Veneroni S, Daidone MG, Tomasic G, Squicciarini P and Salvadori B (1996) p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast cancer patients. J Clin Oncol 14: 1604-1610
45. Siziopikou KP, Prioleau JE, Harris JR and Schnitt SJ (1996) bcl-2 expression in the spectrum of preinvasive breast lesions. Cancer 77: 499-506
46. Sjogren S, Inganas M, Norberg T, Lindgren A, Nordgren H, Holmberg L and Bergh J (1996) The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry. J Natl Cancer Inst 88: 173-182
47. Teixeira C, Reed JC and Pratt MAC (1995) Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oneogene expression in human breast cancer cells. Cancer Res 55: 3902-3907
48. Theodorakis P, D'Sa-Eipper C, Subramanian T and Chinnadurai G (1996) Unmasking of a proliferation-restraining activity of the anti-apoptosis protein EBV BHRFI. Oncogene 12: 1707-1713
49. van de Vijver MJ, Peterse JL and Mooi WJ (1988) Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer. N Engl J Med 319: 1239-1245
50. van Slooten H, Clahsen PC, van Dierendonck JH, Duval C, Pallud C, Mandard A, Delobelle-Deroide A, Van de Velde CJH and van de Vijver MJ (1996) Expression of BCL-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to one course of perioperative chemotherapy. Br J Cancer 74: 78-85
51. Wang Q, Worland PJ, Clark JL, Carlson BA and Sausville EA (1995) Apoptosis in 7-hydroxystaurosporine-treated T lymphoblasts correlates with activation of cyclin-dependent kinases 1 and 2. Cell Growth Different 6: 927-936
52. Wang J, Guo K, Wills KN and Walsh K (1997) Rb functions to inhibit apoptosis during myocyte differentiation. Cancer Res 57: 351-354
53. Wang TT and Phang JM (1995) Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7. Cancer Res 55: 2487-2489
54. Williams BO, Remington L, Albert DM, Mukai S, Bronson RT and Jacks T (1994) Cooperative tumorigenic effects of germline mutations in Rb and p53. Nature Genet 7: 480-484
55. Yao SL, Akhlar AJ, McKenna KA, Bedi GC, Sidransky D, Mabry M, Ravi R, Collector MI, Jones RJ, Sharkis SJ, Fuchs EJ and Bedi A (1996a) Selective radiosensitization of p53-deficient cells by caffeine-mediated activation of p34cdc2 kinase. Nature Med 2: 1140-1143
56. Yao SL, McKenna KA, Sharkis SJ and Bedi A (1996b) Requirement of p34cdc2 kinase for apoptosis mediated by the Fas/APO-1 receptor and interleukin 1beta-converting enzyme-related proteases. Cancer Res 56: 4551-4555
57. Yin XM, Oltvai ZN and Korsmeyer SJ (1995) Heterodimerization with Bax is required for Bcl-2 to repress cell death. Curr Top Microbiol Immunol 194: 331-338
58. Zornig M and Evan GI (1996) Cell cycle: on target with Myc. Current Biol 6: 1553-1556